Uploaded May 2019 | Updated November 2026, 3 hours ago
Congress is deciding whether to approve the USMCA trade agreement (NAFTA 2.0). AAM’s Jonathan Kimball urges Americans to tell their member of Congress to stand up for patients and fix the provisions that increase drug prices and expand drug monopolies. Improving the USMCA by increasing patient access to more affordable generic and biosimilar medicine is possible.
Take Action Now! medsforamerica.org
#FixUSMCA
Congress is deciding whether to approve the USMCA trade agreement (NAFTA 2.0). AAM’s Jonathan Kimball urges Americans to tell their member of Congress to stand up for patients and fix the provisions that increase drug prices and expand drug monopolies. Improving the USMCA by increasing patient access to more affordable generic and biosimilar medicine is possible.
Take Action Now! medsforamerica.org
#FixUSMCA










